GS
Therapeutic Areas
Zomedica Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TRUFORMA® Platform | In-clinic Diagnostic Analyzer | Commercial |
| Total T4 (TT4) Assay | Canine & Feline Hypothyroidism | Commercial |
| Canine TSH (cTSH) Assay | Canine Hypothyroidism | Commercial |
| Free T4 (fT4) Assay | Canine & Feline Thyroid Function | Commercial |
| Canine Cortisol Assay | Canine Cushing's & Addison's Disease | Commercial |
| Feline Cortisol Assay | Feline Cushing's Disease | In Development |
| Equine Cortisol Assay | Equine Metabolic Syndrome, PPID | In Development |
| ZM-020 (Rexacofostat) | Canine Osteoarthritis | Pre-clinical |
Leadership Team at Zomedica Pharmaceuticals
LH
Larry Heaton
Chief Executive Officer
PD
Peter Donato
Chief Financial Officer
DS
Dr. Stephanie Morley
Chief Operating Officer
DG
Dr. Gerald (Gerry) Solensky, Jr.
Executive Chairman of the Board
DJ
Dr. James (Jim) F. Cummings
Chief Science Officer
AM
Ann M. Cotter
Chief Commercial Officer
RC
Robert Cohen
Chief Business Officer
JD
Johnny D. Powers
Board Member
AP
Andrea P. Michaels
Board Member
JS
James S. Latimore
Board Member